Hedge Fund Broadwood Capital Added Over 1 Million Shares of STAAR Surgical to Its Position. Here's What That Means for Investors.

The fund’s quarter-end presumption successful STAAR Surgical decreased successful worth by $45.28 million, a fig that reflects some the further shares acquired and changes successful the banal terms implicit the period.

What other to cognize

• This was a buy, lifting the involvement to 21.25% of Broadwood Capital’s reportable AUM arsenic of March 31, 2026.

• Top holdings aft this filing:

  • NASDAQ:MNST: $587.49 cardinal (41.4% of AUM)

  • NASDAQ:STAA: $301.52 cardinal (21.3% of AUM)

  • NASDAQ:AXON: $294.52 cardinal (20.8% of AUM)

  • NYSEMKT:IWM: $117.78 cardinal (8.3% of AUM)

  • NYSEMKT:LCTX: $78.31 cardinal (5.5% of AUM)

• As of May 14, 2026, shares were priced astatine $32.01, up 83.6% implicit the past twelvemonth and outperforming the S&P 500 by 56.35 percent points.

Company Overview

Company Snapshot

• STAAR Surgical Company develops and sells implantable lenses for imaginativeness correction, including the Visian ICL merchandise household for myopia, hyperopia, astigmatism, and presbyopia, arsenic good arsenic preloaded silicone cataract intraocular lenses and injector systems.

• The institution generates gross chiefly done nonstop income of its proprietary ophthalmic devices and related transportation systems to healthcare providers and distributors.

• Main customers are ophthalmic surgeons, imaginativeness and surgical centers, hospitals, and authorities facilities, with a planetary footprint spanning North America, Europe, and Asia.

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye, leveraging proprietary lens exertion to code a wide scope of refractive errors.

The institution sells its products straight done income representatives successful the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, and done representatives and autarkic distributors successful China, Korea, India, France, Benelux, Italy, and internationally.

What this transaction means for investors

New York-based Broadwood Capital’s acquisition of STAAR Surgical Company shares during the archetypal 4th signals the hedge money has a bullish outlook towards the stock. It already owned implicit 15 cardinal shares astatine the extremity of the 4th fourth of 2025, truthful adding much successful Q1 signals the steadfast believed the banal would admit successful value.